Oragenics Inc. (OGEN)

Name: Oragenics Inc. (OGEN) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Oragenics Inc. (OGEN)

Stock Card

$0.52

$-0.08 (-12.52%)

As on 28-Aug-2026 13:33EDT

Market cap

$2 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

0.6

P/B Ratio

0.7

Div. Yield

0 %

Oragenics (OGEN) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.52 High: 0.53

52 Week Range

Low: 0.50 High: 1.45

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-13.1 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

0.2
Debt to Equity

0
Book Value

$--
EPS

$-198.2
Face value

--
Shares outstanding

4,511,957

10 Years Aggregate

CFO

$-99.14 Mln

EBITDA

$-124.78 Mln

Net Profit

$-133.72 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Oragenics (OGEN)	-32.7	--	-12.5	-52.3	-81.6	-78.8	-63.6
BSE Sensex	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
Oragenics (OGEN)	-93.0	-93.3	-10.7	-75.6	0.2	-14.1	-39.1
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Oragenics (OGEN)	0.5	2.4	0.0	-10.1	--	-168.7	0.6	0.7
Arrowhead Pharmaceuticals (ARWR)	84.9	12,304.7	669.5	-320.0	-0.8	-71.1	--	26.4
Ascendis Pharma A/S - ADR	246.7	16,614.0	1,054.4	755.9	5.7	--	19.4	10.1
Cytokinetics Inc (CYTK)	72.3	10,682.6	71.0	-894.0	-1,175.8	--	--	60.3
Exelixis (EXEL)	54.2	13,400.0	2,435.9	860.6	31.0	43	17	7.3
Halozyme Therapeutics (HALO)	105.3	12,277.1	1,663.7	413.6	36.3	430	31.2	83.9
Krystal Biotech (KRYS)	350.5	10,258.4	440.5	241.5	33.4	18.7	42.2	7.3
Madrigal Pharmaceuticals (MDGL)	534.5	11,938.8	1,283.9	-325.1	-19.0	-57.7	--	22.9
Medpace Holdings (MEDP)	603.9	17,326.2	2,782.3	491.5	21.1	110.1	36.5	39.4
Praxis Precision MedicinesÂ Inc (PRAX)	348.4	10,496.2	0.0	-339.1	--	-30.6	--	7.6

Shareholding Pattern

View Details

About Oragenics (OGEN)

Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic,... non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Lakewood Ranch, Florida. Read more

Executive Chairman

Mr. Charles L. Pope CPA
President & Interim Principal Executive Officer

Mr. Joseph Michael Redmond
Headquarters

Lakewood Ranch, FL
Website

https://www.oragenics.com

FAQs for Oragenics (OGEN)

What is the current share price of Oragenics Inc (OGEN) Today?

The share price of Oragenics Inc (OGEN) is $0.52 (NYSE) as of 28-Aug-2026 13:33 EDT. Oragenics Inc (OGEN) has given a return of -81.6% in the last 3 years.

What is the current PB & PE ratio of Oragenics Inc (OGEN)?

The P/E ratio of Oragenics Inc (OGEN) is 0.55 times as on 21-Aug-2026.
The P/B ratio of Oragenics Inc (OGEN) is 0.65 times as on 21-Aug-2026, a 88 discount to its peers’ median range of 5.35 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-0.34	0.40
2024	-0.23	-11.54
2023	-0.71	4.60
2022	-0.01	0.02
2021	-0.20	0.12

What is the 52 Week High and Low of Oragenics Inc (OGEN)?

The 52-week high and low of Oragenics Inc (OGEN) are Rs 1.45 and Rs 0.50 as of 29-Aug-2026.

What is the market cap of Oragenics Inc (OGEN)?

Oragenics Inc (OGEN) has a market capitalisation of $ 2 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Oragenics Inc (OGEN)?

Before investing in Oragenics Inc (OGEN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.